Mechano-regulation of GLP-1 production by Piezo1 in intestinal L cells

Yanling Huang,Haocong Mo,Jie Yang,Luyang Gao,Tian Tao,Qing Shu,Wenying Guo,Yawen Zhao,Jingya Lyu,Qimeng Wang,Jinghui Guo,Hening Zhai,Linyan Zhu,Hui Chen,Geyang Xu
DOI: https://doi.org/10.1101/2024.04.01.587569
2024-07-02
Abstract:Glucagon-like peptide 1 (GLP-1) is a gut-derived hormone secreted by intestinal L cells and vital for postprandial glycemic control. As open-type enteroendocrine cells, whether L cells can sense mechanical stimuli caused by chyme and thus regulate GLP-1 synthesis and secretion is unexplored. Our study showed expression of Piezo1 in intestinal L cells. Its level varied in different energy status and correlates with blood glucose and GLP-1 levels. Mice with L cell-specific loss of Piezo1 (IntL-Piezo1-/-) exhibited impaired glucose tolerance, increased body weight, reduced GLP-1 production and decreased CaMKKβ/CaMKIV-mTORC1 signaling pathway under normal chow diet or high fed diet. Activation of the intestinal Piezo1 by its agonist Yoda1 or intestinal bead implantation increased the synthesis and secretion of GLP-1, thus alleviated glucose intolerance in diet-induced-diabetic mice. Overexpression of Piezo1, Yoda1 treatment or stretching stimulated GLP-1 production and CaMKKβ/CaMKIV-mTORC1 signaling pathway, which could be abolished by knockdown or blockage of Piezo1 in primary cultured mouse L cells and STC-1 cells. These findings suggest a previously undiscovered mechano-regulation of GLP-1 production in L cells, which may shed new light on the treatments of diabetes.
Physiology
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to explore how the Piezo1 channel in intestinal L - cells regulates the production of glucagon - like peptide - 1 (GLP - 1) under mechanical stimulation. Specifically, the researchers hope to reveal the following points: 1. **Expression and function of Piezo1 in L - cells**: Confirm whether Piezo1 is expressed in intestinal L - cells and whether its expression level changes with the energy state. 2. **Effect of mechanical stimulation on GLP - 1 production**: Explore whether mechanical stimulation (such as peristalsis caused by food passing through the intestine) can regulate the synthesis and secretion of GLP - 1 by activating Piezo1. 3. **Mechanism of signal pathway**: Analyze how Piezo1 regulates the production of GLP - 1 through the CaMKK β/CaMKIV - mTORC1 signal pathway. ### Research background Glucagon - like peptide - 1 (GLP - 1) is a hormone secreted by intestinal L - cells and plays a key role in postprandial blood glucose control. Although it is known that nutrients, neural signals, etc. can stimulate the secretion of GLP - 1, it is still unclear whether L - cells can sense mechanical stimulation from the intestinal lumen contents and thus regulate the production of GLP - 1. ### Research findings The researchers found through experiments: - Piezo1 is expressed in intestinal L - cells, and its expression level is related to blood glucose and GLP - 1 levels. - Under normal diet or high - fat diet conditions, mice with L - cell - specific deletion of Piezo1 showed glucose intolerance, weight gain, and reduced GLP - 1 production. - Activating Piezo1 (for example, through its agonist Yoda1 or intestinal bead implantation) can increase the synthesis and secretion of GLP - 1, thereby improving glucose intolerance in diet - induced diabetic mice. - Over - expression of Piezo1, Yoda1 treatment, or stretch stimulation can enhance the production of GLP - 1 and the activation of the CaMKK β/CaMKIV - mTORC1 signal pathway, and these effects can be eliminated by knocking down or blocking Piezo1. ### Conclusion These findings indicate that Piezo1 mediates mechanical sensing from the intestinal lumen contents in intestinal L - cells and triggers the synthesis and secretion of GLP - 1 through the CaMKK β/CaMKIV - mTORC1 signal pathway, thereby regulating blood glucose homeostasis. This provides new insights for the treatment of type 2 diabetes and lays a theoretical foundation for the development of hypoglycemic drugs targeting Piezo1. ### Key formula The signal pathway involved in this paper can be represented by the following formula: \[ \text{Mechanical stimulation} \xrightarrow{\text{Piezo1}} \text{CaMKK} \beta \rightarrow \text{CaMKIV} \rightarrow \text{mTORC1} \rightarrow \text{GLP - 1 synthesis and secretion} \] Through this mechanism, Piezo1 converts mechanical stimulation into biochemical signals and ultimately affects the production of GLP - 1.